| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.75B | $1.77B | $1.64B |
| YoY Revenue Growth % | -1.2% | +7.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $354.0M | $327.8M | $313.5M |
| Operating Margin % | 20.3% | 18.5% | 19.1% |
| Net Income (GAAP) | $323.5M | $289.2M | $261.2M |
| EBITDA (Normalized) | $1.30B | $1.14B | $372.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $601.8M | $594.4M | $267.0M |
| Capital Expenditures (CapEx) | $1.18B | $1.01B | $73.8M |
| Free Cash Flow (FCF) | -$577.5M | -$414.9M | $193.2M |
| FCF Margin % | -33.1% | -23.5% | 11.8% |
| Return on Invested Capital (ROIC %) | 4.2% | 4.3% | 9.0% |
| Cash & Short-Term Equivalents | $215.7M | $368.9M | — |
| Total Debt (Short + Long Term) | $3.33B | $3.05B | $1.07B |
| Total Stockholders' Equity | $3.57B | $3.33B | $2.19B |